Want to join the conversation?
$COF 2Q15 Call: Excluding the impact from the restructuring charges and the build in UK PPI reserve, EPS was $1.78 and efficiency ratio was 54.6%. Recorded a $36MM benefit from reducing reserve for representation and warranty claims; reduction was driven by recent High Court ruling in New York regarding the application of statute of limitations.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?